Identification of a pathogenic NHLRC1 variant in a consanguineous Pakistani family affected with severe and rapidly progressive Lafora disease. [PDF]
Aslam Z +4 more
europepmc +1 more source
Glycogenin-1 deficiency: a case report and review of the literature. [PDF]
Molitierno N +12 more
europepmc +1 more source
Beneficial Effect of Fingolimod in a Lafora Disease Mouse Model by Preventing Reactive Astrogliosis-Derived Neuroinflammation and Brain Infiltration of T-lymphocytes. [PDF]
Rubio T, Campos-Rodríguez Á, Sanz P.
europepmc +1 more source
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations. [PDF]
Riva A +32 more
europepmc +1 more source
SINEUP-Mediated Overexpression of Endogenous α-Amylase as a Therapeutic Approach in Lafora Disease. [PDF]
Allegri L +8 more
europepmc +1 more source
Mapping Disorders with Neurological Features Through Mitochondrial Impairment Pathways: Insights from Genetic Evidence. [PDF]
Makridou A +6 more
europepmc +1 more source
Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity. [PDF]
Gumusgoz E +13 more
europepmc +1 more source
Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease. [PDF]
Fang Z +5 more
europepmc +1 more source
Spontaneous late-onset myoclonic epilepsy in cats: 15 cases (2015-2023). [PDF]
Liatis T, Karpozilou A, De Stefani A.
europepmc +1 more source
Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice. [PDF]
Zafra-Puerta L +7 more
europepmc +1 more source

